AAAAAA
Results: 351-375/1162
Authors:
Reiland, J
Furcht, LT
McCarthy, JB
Citation: J. Reiland et al., CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor, PROSTATE, 41(2), 1999, pp. 78-88
Authors:
Sandfeldt, L
Hahn, RG
Citation: L. Sandfeldt et Rg. Hahn, Comparison of urological irrigating fluids containing glycine and mannitolin volunteers, PROSTATE, 41(2), 1999, pp. 89-98
Authors:
Chan, PSF
Chan, LW
Xuan, JW
Chin, JL
Choi, HL
Chan, FL
Citation: Psf. Chan et al., In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates, PROSTATE, 41(2), 1999, pp. 99-109
Authors:
Klingler, HC
Bretland, AJ
Reid, SV
Chapple, CR
Eaton, CL
Citation: Hc. Klingler et al., Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGF beta), PROSTATE, 41(2), 1999, pp. 110-120
Authors:
Kuratsukuri, K
Sugimura, K
Harimoto, K
Kawashima, H
Kishimoto, T
Citation: K. Kuratsukuri et al., "Decoy" of androgen-responsive element induces apoptosis in LNCaP cells, PROSTATE, 41(2), 1999, pp. 121-126
Authors:
Drachenberg, DE
Elgamal, AAA
Rowbotham, R
Peterson, M
Murphy, GP
Citation: De. Drachenberg et al., Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer, PROSTATE, 41(2), 1999, pp. 127-133
Authors:
White, RWD
Deitch, AD
Gumerlock, PH
Shi, XB
Citation: Rwd. White et al., Use of a yeast assay to detect functional alterations in p53 in prostate cancer: Review and future directions, PROSTATE, 41(2), 1999, pp. 134-142
Authors:
Juarranz, MG
De Neef, P
Robberecht, P
Citation: Mg. Juarranz et al., Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes, PROSTATE, 41(1), 1999, pp. 1-6
Authors:
Kochera, M
Depinet, TW
Pretlow, TP
Giaconia, JM
Edgehouse, NL
Pretlow, TG
Schwartz, S
Citation: M. Kochera et al., Molecular cytogenetic studies of a serially transplanted primary prostaticcarcinoma xenograft (CWR22) and four relapsed tumors, PROSTATE, 41(1), 1999, pp. 7-11
Authors:
Mairinger, T
Mikuz, G
Gschwendtner, A
Citation: T. Mairinger et al., Nuclear chromatin texture analysis of nonmalignant tissue can detect adjacent prostatic adenocarcinoma, PROSTATE, 41(1), 1999, pp. 12-19
Authors:
Frost, PJ
Belldegrun, A
Bonavida, B
Citation: Pj. Frost et al., Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: Independence of de novo protein synthesis, PROSTATE, 41(1), 1999, pp. 20-30
Authors:
Hsieh, JT
Earley, K
Pong, RC
Wang, Y
Van, NT
Lin, SH
Citation: Jt. Hsieh et al., Structural analysis of the C-CAM I molecule for its tumor suppression function in human prostate cancer, PROSTATE, 41(1), 1999, pp. 31-38
Authors:
Delsite, R
Djakiew, D
Citation: R. Delsite et D. Djakiew, Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: A role in selective neurotrophin stimulation ofprostate epithelial cell growth, PROSTATE, 41(1), 1999, pp. 39-48
Authors:
Virgin, JB
Hurley, PM
Nahhas, FA
Bebchuk, KG
Mohamed, AN
Sakr, WA
Bright, RK
Cher, ML
Citation: Jb. Virgin et al., Isochromosome 8q formation is associated with 8p loss of heterozygosity ina prostate cancer cell line, PROSTATE, 41(1), 1999, pp. 49-57
Authors:
Litwin, MS
Fitzpatrick, JM
Fossa, SD
Newling, DWW
Citation: Ms. Litwin et al., Defining an international research agenda for quality of life in men with prostate cancer, PROSTATE, 41(1), 1999, pp. 58-67
Authors:
Rimler, A
Matzkin, H
Zisapel, N
Citation: A. Rimler et al., Cross talk between melatonin and TGF beta I in human benign prostate epithelial cells, PROSTATE, 40(4), 1999, pp. 211-217
Authors:
McLeod, DG
Schellhammer, PF
Vogelzang, NJ
Soloway, MS
Sharifi, R
Block, NL
Venner, PM
Patterson, AL
Sarosdy, MF
Kelley, RP
Kolvenbag, GJCM
Citation: Dg. Mcleod et al., Exploratory analysis on the effect of race on clinical outcome in patientswith advanced prostate cancer receiving bicalutamide or flutamide, each incombination with LHRH analogues, PROSTATE, 40(4), 1999, pp. 218-224
Authors:
Latil, A
Pesche, S
Valeri, A
Fournier, G
Cussenot, O
Lidereau, R
Citation: A. Latil et al., Expression and mutational analysis of the MADR2/smad2 gene in human prostate cancer, PROSTATE, 40(4), 1999, pp. 225-231
Authors:
Bayne, CW
Donnelly, F
Ross, M
Habib, FK
Citation: Cw. Bayne et al., Serenoa repens (Permixon (R)): A 5 alpha-reductase types I and II inhibitor - New evidence in a coculture model of BPH, PROSTATE, 40(4), 1999, pp. 232-241
Authors:
Djavan, B
Lin, V
Seitz, C
Kramer, G
Kapan, P
Richier, J
Marberger, M
McConnell, JD
Citation: B. Djavan et al., Elastin gene expression in benign prostatic hyperplasia, PROSTATE, 40(4), 1999, pp. 242-247
Authors:
Gann, PH
Klein, KG
Chatterton, RT
Ellman, AE
Grayhack, JT
Nadler, RB
Lee, C
Citation: Ph. Gann et al., Growth factors in expressed prostatic fluid from men with prostate cancer,BPH, and clinically normal prostates, PROSTATE, 40(4), 1999, pp. 248-255
Authors:
Sarkar, FH
Li, YW
Sakr, WA
Grignon, DJ
Madan, SS
Wood, DP
Adsay, V
Citation: Fh. Sarkar et al., Relationship of p21(WAF1) expression with disease-free survival and biochemical recurrence in prostate adenocarcinomas (PCa), PROSTATE, 40(4), 1999, pp. 256-260
Authors:
Hegarty, NJ
Fitzpatrick, JM
Richie, JP
Scardino, PT
White, RWD
Schroder, FH
Coffey, DS
Citation: Nj. Hegarty et al., Future prospects in prostate cancer, PROSTATE, 40(4), 1999, pp. 261-268
Authors:
Pflug, BR
Reiter, RE
Nelson, JB
Citation: Br. Pflug et al., Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines, PROSTATE, 40(4), 1999, pp. 269-273
Authors:
Elstner, E
Campbell, MJ
Munker, R
Shintaku, P
Binderup, L
Heber, D
Said, J
Koeffler, HP
Citation: E. Elstner et al., Novel 20-epi-vitamin D-3 analog combined with 9-cis-retinoic acid markedlyinhibits colony growth of prostate cancer cells, PROSTATE, 40(3), 1999, pp. 141-149